Abstract
Hepatoblastoma is a rare carcinoma mostly seen in children. Neoadjuvant chemotherapy followed by resection and adjuvant chemotherapy is the optimal treatment. We present the case of an 18-year-old woman who presented with abdominal pain, nausea, bloating, and fatigue. MRI showed 3 hepatic lesions with high signal intensity on arterial phase T1-weighted images and slight washout on the late phase, suggestive for hepatocellular carcinoma. Laboratory examinations revealed plasma α-feto-protein of 114,245 μg/L. Subsequent baseline and posttreatment F-fluoromethyl choline PET/CT were performed to possibly evaluate extent of the disease and assess disease response after neoadjuvant chemotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | e80-82 |
| Journal | Clinical Nuclear Medicine |
| Volume | 38 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2013 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver